Min, Ahrum
Kim, Kwangsoo
Jeong, Kyeonghun
Choi, Seongmin
Kim, Seongyeong
Suh, Koung Jin
Lee, Kyung-Hun
Kim, Sun
Im, Seock-Ah
Funding for this research was provided by:
Korea Health Industry Development Institute (HI14C1277)
Article History
Received: 29 January 2020
Accepted: 9 June 2020
First Online: 27 July 2020
Competing interests
: Seock-Ah Im is a recipient of research funds from AstraZeneca Inc., Pfizer and Roche, has consultant and advisory roles for AstraZeneca, Amgen, Eisai, Hanmi Corp, Lilly, MediPacto, Novartis, Pfizer, and Roche. The other authors declare no conflict of interest.